Healthspan taxonomy seed — see taxonomy_path
Current stock research snapshot · 7/31/26 28 days old
SYKStryker
Investment conviction●●○○○2 of 5 · current snapshot
Research target$363.89Current stock price target
Investment thesis statusNEEDS_MORE_DATALast reviewed 7/31/26
Market cap$135.04BSnapshot value · 7/31/26
Stryker Q2 2026 earnings; Mako robotic-assisted surgery procedures; orthopedics demand recovery; neurovascular portfolio; AI-enabled surgery tools
Thesis weakens if Mako stays orthopedics-only as robotics consolidates toward soft-tissue platforms, Ortho Tech growth decelerates below ~10.5%, or $158M one-time tariff reversal + ~$400M tariff headwind compress margins. (vault 2026-08)
Neutral — No investor/analyst mentions of the company found. [X search Aug 2026]
Snapshot · 7/31/26🟡 Mixed · ins-$118.2M · 13F 15+/10-×0.5 · short↓0.17
Snapshot · 7/31/26